SUMMARY Ethnic differences in breast cancer survival have been a long-standing concern. The objective of this review is to present relevant studies for all major U.S. racial/ethnic groups including African Americans, Hispanics, Native Americans, Japanese, and Native Hawaiians, and to discuss underlying causes of disparity. In comparison to Caucasian women, African American women continue to experience the poorest breast cancer specific survival of all ethnic groups in the US. The prognosis for Latinas, Native Hawaiians, and Native Americans is intermediate, better than for African Americans but not as good as for Caucasians, whereas Japanese women tend to have better outcomes. The following possible contributors to the observed differences are discussed in detail: unfavorable distribution of stage at diagnosis due to low screening rates, limited access to care and treatment, tumor type, comorbidities, socioeconomic status, obesity, and physical activity.
Mammographic density is strongly and consistently associated with breast cancer risk. To determine if this association was modified by reproductive factors (parity and age at first birth), data were combined from four case-control studies conducted in the United States and Japan. To overcome the issue of variation in mammographic density assessment among the studies, a single observer re-read all the mammograms using one type of interactive thresholding software. Logistic regression was used to estimate odds ratios (OR) while adjusting for other known breast cancer risk factors. Included were 1699 breast cancer cases and 2422 controls, 74% of whom were postmenopausal. A positive association between mammographic density and breast cancer risk was evident in every group defined by parity and age at first birth (OR per doubling of percent mammographic density ranged between 1.20 and 1.39). Nonetheless, the association appeared to be stronger among nulliparous than parous women (OR per doubling of percent mammographic density = 1.39 vs 1.24; P-interaction = 0.054). However, when examined by study location, the effect modification by parity was apparent only in women from Hawaii and when examined by menopausal status, it was apparent in postmenopausal, but not premenopausal, women. Effect modification by parity was not significant in subgroups defined by body mass index or ethnicity. Adjusting for mammographic density did not attenuate the OR for the association between parity and breast cancer risk by more than 16.4% suggesting that mammographic density explains only a small proportion of the reduction in breast cancer risk associated with parity. In conclusion, this study did not support the hypothesis that parity modifies the breast cancer risk attributed to mammographic density. Even though an effect modification was found in Hawaiian women, none was found in women from the other three locations.
The association of mammographic breast density with breast cancer risk may vary by adiposity. To examine effect modification by body mass index (BMI), the authors standardized mammographic density data from four case-control studies (1994–2002) conducted in California, Hawaii, and Minnesota, and Gifu, Japan. The 1,699 cases and 2,422 controls included 45% Caucasians, 40% Asians, and 9% African-Americans. Using ethnic-specific BMI cut points, 34% were classified as overweight and 19% as obese. A single reader assessed density from mammographic images using a computer-assisted method. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) while adjusting for potential confounders. Modest heterogeneity in the relation between percent density and breast cancer risk across studies was observed (pheterogeneity = 0.08). Cases had a greater age-adjusted mean percent density than controls: 31.7% versus 28.5%, respectively (p <0.001). Relative to <20 percent density, the ORs for >35 were similar across BMI groups whereas the OR for 20–35 was slightly higher in overweight (OR = 1.69, 95% CI: 1.28, 2.24) and obese (OR = 1.62, 95% CI: 1.12, 2.33) than in normal weight women (OR = 1.49, 95% CI: 1.11, 2.01). Furthermore, limited evidence of effect modification by BMI of the OR per 10% increase in percent density (pinteraction = 0.06) was observed, including subgroup analyses by menopausal status and in analyses that excluded women at the extremes of the BMI scale. Our findings indicate little, if any, modification by BMI of the effects of breast density on breast cancer risk.
Choline and betaine are important nutrients for human health, but reference food composition databases for these nutrients became available only recently. We tested the feasibility of using these databases to estimate dietary choline and betaine intakes among ethnically diverse adults who participated in the Multiethnic Cohort (MEC) Study. Of the food items (n = 965) used to quantify intakes for the MEC FFQ, 189 items were exactly matched with items in the USDA Database for the Choline Content of Common Foods for total choline, choline-containing compounds, and betaine, and 547 items were matched to the USDA National Nutrient Database for Standard Reference for total choline (n = 547) and 148 for betaine. When a match was not found, choline and betaine values were imputed based on the same food with a different form (124 food items for choline, 300 for choline compounds, 236 for betaine), a similar food (n = 98, 284, and 227, respectively) or the closest item in the same food category (n = 6, 191, and 157, respectively), or the values were assumed to be zero (n = 1, 1, and 8, respectively). The resulting mean intake estimates for choline and betaine among 188,147 MEC participants (aged 45-75) varied by sex (372 and 154 mg/d in men, 304 and 128 mg/d in women, respectively; P-heterogeneity < 0.0001) and by race/ethnicity among Caucasians, African Americans, Japanese Americans, Latinos, and Native Hawaiians (P-heterogeneity < 0.0001), largely due to the variation in energy intake. Our findings demonstrate the feasibility of assessing choline and betaine intake and characterize the variation in intake that exists in a multiethnic population.
More Institutional Review Boards (IRBs) are requiring written parental consent in school health intervention trials. Because this requirement presents a formidable challenge in conducting largescale research, it is vital for investigators to share effective strategies learned from completed trials. Investigators for the recently completed Project SPLASH (n = 3,716) smoking prevention trial, conducted in 20 Hawaii middle schools, were required to obtain active parental consent for three surveys across 2 years. This case study describes the consent procedures and incentives used in the trial, and their effectiveness. The overall parental response rate was 85.4%. The highest response rate (89.5%) came from the 7th grade baseline survey, where project staff distributed consent materials and provided class-based incentives. In addition, nearly all students (99.0%) with parental permission assented to participate in the three surveys. The experiences in this study lead to several recommendations for future research, including the importance of assuring adequate funds for recruitment and retention in research grants.
Alcohol consumption and mammographic density are established risk factors for breast cancer. This study examined whether the association of mammographic density with breast cancer varies by alcohol intake. Mammographic density was assessed in digitized images for 1,207 cases and 1,663 controls from three populations (Japan, Hawaii, California) using a computer-assisted method. Associations were estimated by logistic regression. When comparing ever to never drinking, mean density was similar and consumption was not associated with breast cancer risk. However, within the Hawaii/Japan subset, women consuming >1 drink/day had a non-significantly elevated relative risk compared to never drinkers. Also in the Hawaii/Japan population, alcohol intake only modified the association between mammographic density and breast cancer in women consuming >1 drink/day (pinteraction=0.05) with significant risk estimates of 3.65 and 6.58 for the 2nd and 3rd density tertiles as compared to 1.57 and 1.61 for never drinkers in Hawaii/Japan. Although these findings suggest a stronger association between mammographic density and breast cancer risk for alcohol consumers, the small number of cases requires caution in interpreting the results.
For this study, 20 schools in Hawaii with close to 4000 participating students were recruited. Student smoking behavior and curriculum implementation were comparable by group status. The intervention study has the potential to elucidate how youth respond to an intervention with student involvement that incorporates cognitive and social action components.
Background. Breast density assessed from mammography is a strong predictor of breast cancer risk, but the strength of the association may vary with adiposity. To examine effect modification by adiposity, we combined data from four case-control studies on breast density that represented an ethnically diverse population with a wide variation in level of adiposity as measured by body mass index (BMI, kg/m2). Methods. We combined data from four case-control studies representing different locations: California, Hawaii and Minnesota in the United States, and Gifu in Japan. All studies included incident breast cancer cases diagnosed between 1994 and 2002 and matched controls representing the underlying case population. One mammographic image per subject was selected, specifically the mammogram at diagnosis for the studies from California, Minnesota, and Japan and the closest prediagnostic mammogram for Hawaii. Percent density was measured by one reader, who was blinded to case status, using a computer-assisted method. Self-reported anthropometric measures were used to classify women as normal, overweight, and obese according to ethnic-specific BMI cut points (<23, 23-27.4, and ≥27.5 for Asian women and <25, 25-29.9, and ≥30 for other ethnic groups). Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) and to evaluate interactions using the likelihood ratio while adjusting for potential confounders, including age and ethnicity. Heterogeneity across studies was marginally significant as assessed by examining density-by-study interaction (P = 0.09) and, therefore, we also adjusted for study-site. Results. The study included 1,699 cases and 2,422 controls of diverse ethnicity: 45% Caucasian, 40% Asian, 9% African-American, and 7% Other. Of these women, we classified 34% as overweight and19% as obese. Age-adjusted mean percent density was significantly greater for cases than for controls: 31.7% versus 28.9%, respectively (P < 0.001). BMI was inversely associated with breast density; the estimated age-adjusted mean percent density was 36.5%, 26.8%, and 19.3% for normal, overweight, and obese, respectively (Ptrend < 0.001). The overall OR for a 10% higher percent density was 1.15 (95% CI: 1.05, 1.18) with higher estimates in overweight (OR: 1.19, 95% CI: 1.09, 1.29) and obese (OR: 1.25, 95% CI: 1.11, 1.41) than normal BMI (OR: 1.11, 95% CI: 1.05, 1.18). The effect modification by BMI was statistically significant (Pinteraction = 0.01). Conclusions. Our findings confirm that the elevated risk of breast cancer associated with breast density differs by level of adiposity, with a higher risk for overweight and obese than normal BMI. Further research is needed to understand the underlying biological reasons for these noted differences in association by adiposity. Citation Information: Cancer Prev Res 2010;3(12 Suppl):B25.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.